A new graded prognostic assessment for brain metastases in differentiated thyroid carcinoma has been developed and validated using data from over 10,000 patients. This tool aims to improve patient stratification and treatment planning.
differentiated thyroid carcinoma specific graded prognostic assessment for brain metastases derivation in a 10 306 patient cohort and external validation
Original title: “A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation.”